VELCADE(R) (Bortezomib) For Injection Showed Unprecedented Results In Newly Diagnosed Multiple Myeloma Patients

Thu, 22 Jun 2006 11:00 AM EST

... MillenniumPharmaceuticals, Inc. (Nasdaq: MLNM) today announced results of a studythat showed VELCADE in combination with melphalan and prednisone (V-MP)appeared significantly superior to melphalan and prednisone (MP) alone intreating elderly patients with newly diagnosed multiple myeloma (MM) whowere ineligible for stem cell transplantation. [click link for full article] ...